Company profile
A3P Biomedical company profile
A3P Biomedical provides prostate cancer diagnosis and treatment. They specialize in advanced prostate cancer diagnostics. Their main product, Stockholm3, is a clinically and commercially validated blood test for the early detection of aggressive prostate cancer. The test combines protein markers, genetic markers, and clinical data in a proprietary algorithm for the purpose of detecting aggressive prostate cancer at an early stage.
Business identity
- Website
- https://www.a3p.com
- Contact email
- [email protected]
- Phone number
- +46 10 1823301
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $10K+
- Founded
- 2020-01-01
Headquarters
- Headquarters
- Artëm, Primorye, Russia
- Country code
- RU
- Continent
- Europe